Intrinsic value of Viridian Therapeutics, Inc. (VRDN)
Live fair value data for Viridian Therapeutics, Inc. (VRDN) is currently unavailable. Please check again shortly.
Current Price: $414.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Viridian Therapeutics, Inc. (VRDN) undervalued or overvalued?
Based on the current model output, Viridian Therapeutics, Inc. appears to be overvalued with a downside of 3.00%.
Fair value vs market price — Viridian Therapeutics, Inc. (VRDN)
Unlock premium access to view the live fair value comparison against current market price for VRDN.
Frequently Asked Questions - VRDN
How is VRDN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for VRDN.
Is VRDN undervalued or overvalued right now?
VRDN is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for VRDN: open their intrinsic value pages.